Back to Uracil-peptide-pyrene conjugates research
uracil-peptide-pyrene conjugates other in vitro n preclinical 2026-04-17 PubMed

Novel Peptide-Pyrene Probes Offer Sensitive Copper Detection in Biological Systems

Uracil-Peptide-Pyrene Conjugates as Cu2+-Sensitive Probes Targeting DNA, RNA, and Biorelevant Model Membranes.

Background

Copper ions (Cu2+) are essential trace elements for numerous biological processes, but their dysregulation is implicated in various neurodegenerative diseases (e.g., Alzheimer's, Parkinson's) and cancers. Accurate and sensitive detection of Cu2+ in complex biological environments is crucial for understanding disease mechanisms and developing diagnostics. However, existing methods often lack the specificity, sensitivity, or ability to monitor copper in situ within diverse biological targets like DNA, RNA, and cell membranes.

Results

The synthesized Uracil-Peptide-Pyrene conjugates successfully demonstrated Cu2+-sensitive properties, exhibiting distinct and measurable changes in their spectroscopic profiles upon interaction with copper ions. These changes, such as alterations in fluorescence intensity or emission wavelength, indicate their potential as effective and selective sensors for Cu2+. > The most significant finding was the successful design and validation of these conjugates as Cu2+-sensitive probes, capable of responding to the presence of copper ions with measurable spectroscopic alterations, thereby enabling their detection. Furthermore, the conjugates showed specific binding and interaction with DNA and RNA, suggesting their ability to target and potentially monitor copper levels associated with nucleic acids within biological systems. They also demonstrated favorable interactions with biorelevant model membranes, indicating their capacity to associate with or penetrate cellular barriers, which is crucial for potential in vivo applications. The observed multi-target recognition capabilities highlight the versatility of these novel probes.

Why It Matters

This research represents a significant step forward in developing advanced tools for copper ion detection in complex biological matrices. The ability of these Uracil-Peptide-Pyrene conjugates to act as Cu2+-sensitive probes that interact with DNA, RNA, and membranes simultaneously opens new avenues for understanding copper's role in health and disease. This could lead to the development of novel diagnostic agents or imaging tools for conditions linked to copper dysregulation, such as neurodegenerative disorders or certain cancers. Future work will likely involve in vivo studies and further optimization to assess their efficacy and safety in living systems, potentially paving the way for clinical translation.


uracil-peptide-pyrene conjugates other dna rna
Source: pubmed:41996585 · Ingested 2026-04-17 · Digest: gemini-2.5-flash